1. Male genitourinary reconstruction and trauma
2. Use of angioembolization in urology: a review
3. Robotics and urologic reconstructive surgery
4. Long-term complications of continent catheterizable channels: a problem for transitional urologists
5. Anatomy and techniques in posterior urethroplasty
6. Posterior urethral stenosis after prostate cancer treatment: contemporary options for definitive management
7. Current management of pelvic fracture urethral injuries: to realign or not?
8. Contemporary surgical and non-surgical management of Peyronie’s disease
9. Evaluation and management of adult acquired buried penis
10. Novel surgical techniques in female to male gender confirming surgery
11. Penile transplantation: the US experience and institutional program set-up
12. Military genitourinary injuries: past, present, and future
13. Stem cell in urology—are we at the cusp of a new era?
14. International volunteerism and urethral stricture disease: a review
15. Training in reconstructive urology: the past, present and future
16. Contemporary management of ejaculatory dysfunction
17. Urethral diverticulum carcinoma in females—a case series and review of the English and Japanese literature
18. Is sexual education an important skill to teach in medical schools?
19.What can the National Cancer Database tell us about disparities in advanced bladder cancer outcomes?
20. The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
21. Bladder utility symptom scale: a new patient reported outcome measure for health-related quality of life in bladder cancer
22. Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases
23. Open radical cystectomy: lessons from the British Association of Urological Surgeons (BAUS) registry
24. Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer
25. The role of antibiotic prophylaxis after radical cystectomy in preventing urinary tract infections and readmission for sepsis
26. Exploring trends in advanced bladder cancer using the NCDB: turning data into information and information into insight
27. Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
28. Stage T1 bladder cancer: historic background and latest tracks for its demystification
1. 譯者報名表下載連結請見「閱讀原文」
填寫完畢後發送到：rlxt@amegroups.com；
2. 編輯部會綜合選擇最匹配的專家參與翻譯工作，並給符合要求的專家註冊系統帳號和獲取稿件等信息；
3. 每位會員/譯者同時認領的專刊不得超過3本，同一本專刊同時認領的文章不得超過3篇；編輯部將會調整超額認領的譯者的任務情況；
註：凡是通過編輯部審核並註冊系統帳號的專家，我們將會在系統委員風採上展示您的個人風採（包括姓名，科室和簡介）。
4. 以上所有文章都將刊登在AME電子書APP。
凡翻譯質量通過審核的譯者，可獲得：
1. 每翻譯一篇文章，即可獲得200快幣，可換購各種圖書/雜誌/禮品。（了解更多：AME十周年獻禮第一彈，有快幣的換起來！；AME筆記本上新，手快有手慢無；別業風華，大師典藏 | AME十周年獻禮第三彈來了，數量有限，先到先得！）
2. 譯者署名權。
3. 譯者證書
李瀟，男，江蘇省腫瘤醫院泌尿外科醫師。發表第一（並一）/通訊作者SCI論文40篇，單篇影響因子最高9.6分，累計影響因子100餘分。發表中文文章10餘篇，包括中華系列第一作者文章3篇。已授權國家實用新型專利21項，國家發明專利3項，軟體著作權4項。參編中文書籍3本，參編英文書籍1本（任副主編），參譯書籍/特刊40餘本。獲得江蘇省新技術引進獎二等獎一項（排名第2）。主持國自然青年基金，江蘇省衛計委科研面上項目，南京醫科大學教育研究課題，江蘇省腫瘤醫院院級課題和青藍計劃人才項目。目前擔任4本英文雜誌學術編輯，擔任JCO中文版翻譯。
譯者招募點擊速查11本SCI期刊最新影響因子👆
責任編輯：袁 舒 AME Publishing Company
排版編輯：劉佳佳 AME Publishing Company
t.01.2019.08.16.03